PSOLAR: Design, utility, and preliminary results of a prospective, international, disease-based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents

导出原文传递

翻译打印收藏纠错

作者： Papp,K.A. ^[1] ; Strober,B. ^[2] ; Augustin,M. ^[3] ; Calabro,S. ^[4] ; Londhe,A. ^[5] ; Chevrier,M.

作者单位： Janssen Research and Development, LLC, Horsham, PA, United States ^[1] Probity Medical Research, Waterloo, ON, Canada, University of Connecticut School of Medicine ^[2] Probity Medical Research, Waterloo, ON, Canada ^[3] Jenssen Biotech,Inc., Horsham, PA, United States ^[4] University Clinics of Hamburg, Hamburg, Germany ^[5]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of drugs in dermatology

2012年11卷10期

1210-1217页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

PSOLAR: Design, utility, and preliminary results of a prospective, international, disease-based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents

Journal of drugs in dermatology

相似文献

Journal of drugs in dermatology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

PSOLAR: Design, utility, and preliminary results of a prospective, international, disease-based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents

Journal of drugs in dermatology

相似文献

Journal of drugs in dermatology

相关期刊

检索历史清除